Psoriasis Clinical Trials

Showing 181-200 of 888 trials

A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

NCT06643260

This is a double-blind, placebo-controlled study in adults with a diagnosis of moderate-to-severe chronic plaque psoriasis to test the efficacy and safety of piclidenoson in this patient population.

Plaque Psoriasis

Can-Fite BioPharma705 participantsStarted Jun 2025

COMPLETEDPhase 1

A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis

NCT05252533

The purpose of the study is to evaluate pharmacokinetics (PK) of ustekinumab in juvenile psoriatic arthritis (jPsA) and pediatric psoriasis (PsO).

Juvenile Psoriatic ArthritisPsoriasisArthritis, Juvenile

Janssen Research & Development, LLC31 participantsStarted May 2022

Huntington Beach, California, United States • Los Angeles, California, United States • Chicago, Illinois, United States +7 more locations

COMPLETEDPhase 2

A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics

NCT05970978

This is a multicenter, open-label study aim to evaluate the efficacy and safety of IBI112 in Chinese participants with plaque psoriasis who were treated with biologics and switched to IBI112. The study will enroll 160 participants who were diagnosed with plaque psoriasis. The whole study consists of 4 weeks of screening, 32 or 36 weeks of treatment and a safety follow-up visit at Week 44.

Psoriasis

Innovent Biologics (Suzhou) Co. Ltd.152 participantsStarted Aug 2023

Jinan, Shandong, China

A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis

A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics

Related Searches

Biologic Treatment Registry Across Canada

Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients

A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)

A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis

Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

HIPPOCRATES Prospective Observational Study

WORKWELL: Testing Work Advice for People With Arthritis

A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis

Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis

Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy Controls

A Real-World Study of Biologic Therapy for Subclinical Psoriatic Arthritis

A Clinical Study of TQH2929 in Healthy Adult Subjects

Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Bioequivalence Test of Hemay005 Tablets

Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics